News Roundup: May 24, 2018: A Visit to a Chinese Fentanyl Lab
Bloomberg reporters track down an "illicit" fentanyl lab operator in China, but Chinese authorities say he isn't breaking the law.
News Roundup: May 18, 2018: ONDCP Is A No-Show
At one level, the federal government is working with unprecedented dedication to curb the opioid crisis.
News Roundup: May 11, 2018: Mothers With Addiction
In America, a baby is born with opioid withdrawal symptoms every 15 minutes.
News Roundup: May 4, 2018: The Insys Saga
This week’s New York Times Magazine story about Insys Therapeutics—whose founder and six top former officials have all been criminally charged under the Racketeer Influenced and Corrupt Organizations Act—is a rip-roaring yarn, but one that also reveals severe problems with US pharmaceutical marketing practices.
News Roundup, April 27, 2018: Symbolic Apogees
The opioid crisis reached emblematic apogees this week.
News Roundup: April 20, 2018: Despite Exposé, Law Still Curbs DEA Power
As the House Energy & Commerce Committee prepares to mark up about 60 individual, opioid-related bills, and the Senate Health Committee continues to craft and tweak a massive, comprehensive bill, one provision is conspicuous by its absence from all of the above.
News Roundup: April 17, 2018: Judge Sets Model Trial Dates
As of yesterday, 598 lawsuits against opioid manufacturers and distributors, brought mainly by municipalities, were pending before US District Judge Dan Polster in Cleveland.
News Roundup: April 10, 2018: How Chummy Should Government and Nonprofits Get With Pharma?
The public-private partnership that has now been in preparation for almost a year, in which NIH and FDA, on the one hand, will work with the pharmaceutical industry...
News Roundup: April 5, 2018: Stopping Overdose Death Among Newly Released Prisoners
One of the most unsung acts of the Trump Administration could also be one of its most substantive in combatting the opioid epidemic.